Cargando…

Commentary: APP as a Mediator of the Synapse Pathology in Alzheimer's Disease

Detalles Bibliográficos
Autores principales:	Schreurs, An, Latif-Hernandez, Amira, Uwineza, Alice
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5990595/ https://www.ncbi.nlm.nih.gov/pubmed/29905239 http://dx.doi.org/10.3389/fncel.2018.00150

Ejemplares similares

Targeting the Synapse in Alzheimer’s Disease
por: Jackson, Johanna, et al.
Publicado: (2019)

Synapses, Microglia, and Lipids in Alzheimer’s Disease
por: Paasila, Patrick J., et al.
Publicado: (2022)

Commentary: Analysis of SUMO1-conjugation at synapses
por: Wilkinson, Kevin A., et al.
Publicado: (2017)

Phospho-Tau and Cognitive Decline in Alzheimer's Disease. Commentary: Tau in physiology and pathology
por: DeFelipe, Javier
Publicado: (2016)

Response: Commentary: Analysis of SUMO1-conjugation at synapses
por: Daniel, James A., et al.
Publicado: (2018)

Single-synapse analyses of Alzheimer’s disease implicate pathologic tau, DJ1, CD47, and ApoE
por: Phongpreecha, Thanaphong, et al.
Publicado: (2021)

APP Protein Family Signaling at the Synapse: Insights from Intracellular APP-Binding Proteins
por: Guénette, Suzanne, et al.
Publicado: (2017)

Tau Oligomers: The Toxic Player at Synapses in Alzheimer’s Disease
por: Guerrero-Muñoz, Marcos J., et al.
Publicado: (2015)

Synapses, Synaptic Activity and Intraneuronal Aβ in Alzheimer's Disease
por: Tampellini, Davide, et al.
Publicado: (2010)

Commentary: GARLH Family Proteins Stabilize GABA(A) Receptors at Synapses
por: Cho, Chang-Hoon
Publicado: (2017)

Alzheimer’s disease as a synaptopathy: Evidence for dysfunction of synapses during disease progression
por: Meftah, Soraya, et al.
Publicado: (2023)

The Role of Glial Cells and Synapse Loss in Mouse Models of Alzheimer’s Disease
por: Ziegler-Waldkirch, Stephanie, et al.
Publicado: (2018)

A Novel hAPP/htau Mouse Model of Alzheimer's Disease: Inclusion of APP With Tau Exacerbates Behavioral Deficits and Zinc Administration Heightens Tangle Pathology
por: Lippi, Stephen L. P., et al.
Publicado: (2018)

Modifications and Trafficking of APP in the Pathogenesis of Alzheimer’s Disease
por: Wang, Xin, et al.
Publicado: (2017)

Targeting Amyloidogenic Processing of APP in Alzheimer’s Disease
por: Zhao, Jing, et al.
Publicado: (2020)

Targeting Microglia-Synapse Interactions in Alzheimer’s Disease
por: Piccioni, Gaia, et al.
Publicado: (2021)

Intranasal BMP9 Ameliorates Alzheimer Disease-Like Pathology and Cognitive Deficits in APP/PS1 Transgenic Mice
por: Wang, Zigao, et al.
Publicado: (2017)

Commentary: L-3-n-butylphthalide Rescues Hippocampal Synaptic Failure and Attenuates Neuropathology in Aged APP/PS1 Mouse Model of Alzheimer's Disease
por: Bhatt, Prakash C., et al.
Publicado: (2017)

The Role of Astrocytes in Synapse Loss in Alzheimer's Disease: A Systematic Review
por: Hulshof, Lianne A., et al.
Publicado: (2022)

Regional contributions of D-serine to Alzheimer’s disease pathology in male App(NL–G–F/NL–G–F) mice
por: Ni, Xiance, et al.
Publicado: (2023)

Genetic and pharmacologic proteasome augmentation ameliorates Alzheimer’s-like pathology in mouse and fly APP overexpression models
por: Chocron, E. Sandra, et al.
Publicado: (2022)

Age-Dependent Shift of AMPA Receptors From Synapses to Intracellular Compartments in Alzheimer’s Disease: Immunocytochemical Analysis of the CA1 Hippocampal Region in APP/PS1 Transgenic Mouse Model
por: Martín-Belmonte, Alejandro, et al.
Publicado: (2020)

Commentary: Donepezil enhances understanding of degraded speech in Alzheimer's disease
por: Campbell, Tom A., et al.
Publicado: (2018)

APP and APLP2 interact with the synaptic release machinery and facilitate transmitter release at hippocampal synapses
por: Fanutza, Tomas, et al.
Publicado: (2015)

Gut microbiota may be involved in Alzheimer’s disease pathology by dysregulating pyrimidine metabolism in APP/PS1 mice
por: Feng, Min, et al.
Publicado: (2022)

Is phosphorylated tau a good biomarker of synapse pathology in Alzheimer’s disease?
por: Saura, Carlos A, et al.
Publicado: (2023)

The Role of Mesenchymal Stem Cells in Regulating Astrocytes-Related Synapse Dysfunction in Early Alzheimer’s Disease
por: Liu, Cong
Publicado: (2022)

Early Cognitive and Behavioral Deficits in Mouse Models for Tauopathy and Alzheimer’s Disease
por: Samaey, Celine, et al.
Publicado: (2019)

Commentary: The Case for Abandoning Therapeutic Chelation of Copper Ions in Alzheimer’s Disease
por: Squitti, Rosanna, et al.
Publicado: (2017)

MicroRNAs as Potential Orchestrators of Alzheimer's Disease-Related Pathologies: Insights on Current Status and Future Possibilities
por: Abuelezz, Nermeen Z., et al.
Publicado: (2021)

Impacts of Acute Hypoxia on Alzheimer's Disease-Like Pathologies in APP(swe)/PS1(dE9) Mice and Their Wild Type Littermates
por: Zhang, Feng, et al.
Publicado: (2018)

Transplantation of Human Menstrual Blood-Derived Mesenchymal Stem Cells Alleviates Alzheimer’s Disease-Like Pathology in APP/PS1 Transgenic Mice
por: Zhao, Yongjia, et al.
Publicado: (2018)

Disinhibition-Mediated LTP in the Hippocampus is Synapse Specific
por: Ormond, Jake, et al.
Publicado: (2011)

A genetic variant of the Wnt receptor LRP6 accelerates synapse degeneration during aging and in Alzheimer’s disease
por: Jones, Megan E., et al.
Publicado: (2023)

Neuroprotective effects of resveratrol in Alzheimer disease pathology
por: Rege, Shraddha D., et al.
Publicado: (2014)

Alzheimer's Disease: Tau Pathology and Dysfunction of Endocytosis
por: Ando, Kunie, et al.
Publicado: (2021)

Accelerated Dystrophy and Decay of Oligodendrocyte Precursor Cells in the APP/PS1 Model of Alzheimer’s-Like Pathology
por: Chacon-De-La-Rocha, Irene, et al.
Publicado: (2020)

Emerging Roles of Astrocytes in Neuro-Vascular Unit and the Tripartite Synapse With Emphasis on Reactive Gliosis in the Context of Alzheimer’s Disease
por: Liu, Cai-Yun, et al.
Publicado: (2018)

Repeat propofol anesthesia does not exacerbate plaque deposition or synapse loss in APP/PS1 Alzheimer’s disease mice
por: Woodhouse, Adele, et al.
Publicado: (2018)

Prodromal Alzheimer’s Disease: Constitutive Upregulation of Neuroglobin Prevents the Initiation of Alzheimer’s Pathology
por: de Vidania, Silvia, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_m831h8lkt122vva6ka6ddif23d